FindTrial
Sign In

Canceled by the investigator. Early warning prediction of patients with severe novel coronavirus pneumonia (COVID-19) based on multiomics

Early warning prediction of patients with severe novel coronavirus pneumonia (COVID-19) based on multiomics

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000029866
Enrollment
Unknown
Registered
2020-02-15
Start date
2020-02-17
Completion date
Unknown
Last updated
2023-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

novel coronavirus pneumonia (COVID-19)

Interventions

Gold Standard:Diagnostic criteria for severe novel coronavirus pneumonia.
Index test:early warning and prediction system.

Sponsors

Enze Hospital of Taizhou Enze Medical Center (Group)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Aged >18 years; 2. Laboratory (RT-PCR) confirmed infection with 2019-nCoV; 3. Lung involvement confirmed with chest imaging.

Exclusion criteria

Exclusion criteria: Pregnant women.

Design outcomes

Primary

MeasureTime frame
Cytokine detection;Lymphocyte subpopulation analysis ;SEN, SPE, ACC, AUC of ROC;—

Countries

China

Contacts

Public ContactLyu Dongqing

Enze Hospital of Taizhou Enze Medical Center (Group)

lvdq@enzemed.com+86 13867622009

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 18, 2026